Beyond these pathways, inhibition of the HMGB1 pathway, an emerging strategy with demonstrated efficacy in preclinical models of sepsis and intestinal I/R-related ALI (39, 91), represents another potential avenue for disrupting upstream inflammatory cascades in AAD. This evidence concerns the gene HMGB1 and acute respiratory distress syndrome.